Neurobehavioral & Cognitive Disorders
Familial Alzheimer disease
Sep. 23, 2024
Professor Emeritus
Department of Neurology
Indiana University School of Medicine
Editorial Board Member 2001-2023: Behavioral Disorders
Clinical and Research Interests: Alzheimer Disease, dementias
Contributor Disclosures
Dr. Farlow of Indiana University received research grant support from AbbVie, Biogen, Boehringer Ingelheim, Eisai, Eli Lilly, Genentech, Roche, Novartis, Suven Life Sciences Ltd, and vTv Therapeutics; fees from Cerecin/Accera, Allergan, Avanir, AZ Therapies, Eli Lilly, Kyowa Kirin Pharma, Longeveron, Medavante, Merck, Neurotrope Biosciences, Proclara, Takeda, and vTv Therapeutics for consultancy, or advisory board/DSMB membership; patent licensing fees from Elan; and consulting fees from Cortexyme, Green Valley, Regenera, Samumed, Zhejiang Hisun Pharmaceuticals, Cognition Therapeutics, Danone, Eisai, and Otsuka.